The expression of Bcl-2 at both the transcription and protein levels in vitro and in vivo was efficiently inhibited by the CNCs; this inhibition effect increased the sensitivity of the cancer cells to DTX and subsequently induced enhanced apoptosis. Here, BCL2 is linked to cancer.